BIOMAT Database Logo BIOMAT Database Logo

Tardive dyskinesia associated with metoclopramide. 1978

S Lavy, and E Melamed, and S Penchas

UI MeSH Term Description Entries
D008297 Male Males
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D004409 Dyskinesia, Drug-Induced Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) Dyskinesia, Medication-Induced,Medication-Induced Dyskinesia,Drug-Induced Dyskinesia,Drug-Induced Dyskinesias,Dyskinesia, Drug Induced,Dyskinesia, Medication Induced,Dyskinesias, Drug-Induced,Dyskinesias, Medication-Induced,Medication Induced Dyskinesia,Medication-Induced Dyskinesias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

S Lavy, and E Melamed, and S Penchas
Tardive dyskinesia associated with metoclopramide.
February 1984, British medical journal (Clinical research ed.),
S Lavy, and E Melamed, and S Penchas
Tardive dyskinesia associated with metoclopramide.
March 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
S Lavy, and E Melamed, and S Penchas
Tardive dyskinesia associated with high-dose intravenous metoclopramide.
August 1986, The New England journal of medicine,
S Lavy, and E Melamed, and S Penchas
Metoclopramide and tardive dyskinesia.
November 1994, Biological psychiatry,
S Lavy, and E Melamed, and S Penchas
Tardive dyskinesia and metoclopramide.
December 1979, Lancet (London, England),
S Lavy, and E Melamed, and S Penchas
Metoclopramide in tardive dyskinesia.
April 1983, Indian journal of psychiatry,
S Lavy, and E Melamed, and S Penchas
Metoclopramide induced tardive dyskinesia.
September 1991, Journal of the Indian Medical Association,
S Lavy, and E Melamed, and S Penchas
Tardive dyskinesia associated with metoclopramide in persons with developmental disabilities.
January 2002, Research in developmental disabilities,
S Lavy, and E Melamed, and S Penchas
Tardive dyskinesia associated with use of metoclopramide in a child.
December 1992, The Journal of pediatrics,
S Lavy, and E Melamed, and S Penchas
Parkinsonism and tardive dyskinesia associated with long-term metoclopramide therapy.
December 1981, The New England journal of medicine,
Copied contents to your clipboard!